GlassScriptPhysician profile
Olubusola Abiola Ogunlade
NPI 1194046375
$856.15
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $318 · 2021: $159 · 2023: $173 · 2024: $26.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $433.76 | 2019-2023 | |
| Hologic Sales and Service, LLC | $98.26 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $64.17 | 2023-2024 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $63.73 | 2020-2021 | |
| Pfizer INC. | $60.77 | 2023 | |
| Novo Nordisk INC | $34.30 | 2023 | Wegovy |
| Evofem Biosciences, INC. | $32.77 | 2020-2021 | |
| Exeltis, USA INC. | $21.57 | 2023 | Slynd |
| Therapeuticsmd, INC. | $16.45 | 2021 | |
| Baudax Bio INC. | $15.48 | 2020 | |
| Dysis Medical, INC. | $11.92 | 2020 | |
| Intuitive Surgical, INC. | $2.97 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olubusola Ogunlade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.